References
- ChiouYYPitmanMBHahnPFRare benign and malignant appendiceal lesions: spectrum of computed tomography findings with pathologic correlationJ Comput Assist Tomogr200327329730612794590
- FuLOsugaYMorimotoCDienogest inhibits BrdU up-take with G0/G1 arrest in cultured endometriotic stormal cellsFertil Steril200889Suppl 51344134717511992
- OettelMCarolWElgerWA 19-norprogestin without 17 α-ethinyl group II: dienogest from a pharmacodynamic point of viewDrugs Today19953127517536
- SasagawaSShimizuYNagaokaTTokadoHImadaKMizuguchiKDienogest, a selective progestin, reduces plasma estradiol level through induction of apoptosis of granulose cells in the ovarian dominant follicle without follicle-stimulating hormone suppression in monkeysJ Endocrinol Invest20083163664118787383
- HaradaTMomoedaMTaketaniYDienogest is as effective as intranasal buserelin acetate for the relief of pain symptoms associated with endometriosis – a randomized, double-blind, multicenter, controlled trialFertil Steril200991367568118653184
- StrowitzkiTMarrJGerlingerCDienogest is as effective as leuprolide acetate in treating the painful symptoms of endometriosis: a 24-week, randomized, multicentre, open-label trialHum Reprod20102563364120089522
- KöhlerGFaustmannTAGerlingerCHA dose-ranging study to determine the efficacy and safety of 1, 2, and 4 mg of dienogest daily for endometriosisInt J Gynecol Obstet20101082125
- YanaseT[Alleviation of atypical genital bleeding by dienogest treatment: a clinical report]Hormone Frontier in Gynecology20091646873 Japanese
- KitawakiJKusukiIYamanakaKMaintenance therapy with dienogest following gonadotropin-releasing hormone agonist treatment for endometriosis-associated pelvic painEur J Obstet Gynecol Reprod Biol2011157221221621474232
- HaradaMOsugaYIzumiGDienogest, a new conservative strategy for extragenital endometriosis: a pilot studyGynecol Endocrinol9201127971772021158494